Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Durfee

Showing results (481-490 of 485) with videos related to

Pageof 49
Sort By:
You have reached the last page of results.This site can display upto 485 results.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Science (New York, N.Y.)|August 4, 2012
Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiencyDusan Bogunovic, Minji Byun, Larissa A Durfee, et al.
Journal of Neuroengineering and Rehabilitation|November 8, 2017
How a diverse research ecosystem has generated new rehabilitation technologies: Review of NIDILRR's Rehabilitation Engineering Research CentersDavid J Reinkensmeyer, Sarah Blackstone, Cathy Bodine, et al.
The CRISPR Journal|February 14, 2024
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-CasBrian T Burger, Benjamin P Beaton, Matthew A Campbell, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 49

Showing results (481-490 of 485) with videos related to

Sort By:
Pageof 49
You have reached the last page of results.This site can display upto 485 results.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Science (New York, N.Y.)|August 4, 2012
Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiencyDusan Bogunovic, Minji Byun, Larissa A Durfee, et al.
Journal of Neuroengineering and Rehabilitation|November 8, 2017
How a diverse research ecosystem has generated new rehabilitation technologies: Review of NIDILRR's Rehabilitation Engineering Research CentersDavid J Reinkensmeyer, Sarah Blackstone, Cathy Bodine, et al.
The CRISPR Journal|February 14, 2024
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-CasBrian T Burger, Benjamin P Beaton, Matthew A Campbell, et al.
Nature Genetics|December 4, 2023
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistanceDeborah R Caswell, Philippe Gui, Manasi K Mayekar, et al.
Pageof 49